Auteur
CEO bij Orikami
Nijmegen, Nederland
Orikami partners with MedTech companies that are building portfolios of (digital) biomarkers and clinical algorithms. We provide a regulated backend platform to run clinical validation studies and to operate multiple algorithms as Software as a Medical Device (SaMD) in routine care, with continuous compliance built in. If you want to focus on your clinical and product innovation while outsourcing infrastructure, data capture and SaMD lifecycle management, we should talk.
Kennisinstelling
Bedrijf
CEO
Orikami
CEO bij Orikami
Nijmegen, Nederland